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ABSTRACT
Background  Postoperative inflammation is associated 
with cancer progression in several cancers. However, 
the prognostic significance of postoperative fever 
remains unclear in gastric cancer patients.







early gastric cancer (P = 0.0072), no venous  invasion 
(P = 0.025), laparoscopic gastrectomy (P = 0.027), and 
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Gastric cancer  is one of  the most common malignan-





is  required  to  improve  the prognosis  for patients with 
gastric cancer.
Gastrectomy with  regional  lymph node dissection 
is  the mainstay of gastric cancer  treatment  to achieve 
cure. However, many patients with gastric  cancer 
experience  recurrence even after  complete  tumor 
removal  (R0  resection). Early detection of  recurrence 
may contribute  to  survival after curative gastrectomy 















nostic value of postoperative  fever  in breast cancer  [5, 
6] and colorectal cancer [7–9]; however, the prognostic 
significance of postoperative  fever  remains unclear 


















ROC, receiver operating characteristic
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findings were determined according  to  the  Japanese 





patients underwent  radiation  therapy.  In principle, 
early GC patients visit our outpatient clinic every 6 
months  for  the  first 2 years and every 12 months  for 





outpatient clinic every 3 months  for  the  first 2 years 
and every 6 months for 3 years following the operation. 








measured with an axillary  thermometer at  least  four 
times a day after surgery, and the highest one was used 

























































those with early gastric cancer (P = 0.0072), no venous 
invasion (P = 0.025),  laparoscopic gastrectomy  (P = 
0.027), and either proximal or distal partial gastrectomy 
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overall  survival of 5.5  (AUC = 0.6168, P = 0.00016). 
Based on these results, we divided patients into the fol-
lowing groups: prolonged postoperative  fever duration 
group (≥ 6 days at ≥ 37°C, n = 210) and a nonprolonged 
postoperative fever group (≤ 5 days at ≥ 37°C, n = 232). 
The usages of anti-inflammatory analgesic,  such as 















postoperative  fever group,  respectively) and  the differ-
ence was statistically significant  (P = 0.0008, Fig. 3a). 
Five-year disease  specific  survival  (DSS) rates were 
85.7% vs. 92.1% (prolonged postoperative group vs. 
nonprolonged postoperative  fever group,  respectively) 
and the difference was statistically significant (P = 0.032, 
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the difference was statistically  significant  (P = 0.0067, 





It  is widely accepted  that  inflammation plays a  role  in 
tumor pathogenesis,  and  that an  inflammatory micro-
environment  is an essential  component of all  tumors.4 
A recent study also demonstrated that postoperative in-
flammation worsened the prognosis of cancer patients.5 
In  routine clinical  settings,  some serum markers,  such 
as C-reactive protein (CRP) and white blood cell, neu-
trophil,  and  thrombocyte counts,  are used  to evaluate 




with prognosis in cancer patients.5, 6 We also previously 
reported that postoperative neutrophil-lymphocyte ratio 
measured 1 month after operation was significantly cor-
related with prognosis in gastric cancer patients.7
Fever  is a  simple and useful  indicator  to evaluate 
patients’  inflammation status and  is easier and more 
noninvasive  than measuring serum markers. However, 
the prognostic  significance of  fever  remains unclear 
in gastric cancer patients. Regarding  the correlation 
between prognosis and  fever, Yan et al. demonstrated 
that postoperative fever was an independent prognostic 
factor  for  relapse-free  survival  in node-negative breast 
cancer patients.8 They defined fever as an oral tempera-
ture ≥ 38°C in one week postoperation, which was simi-
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fever ≥ 38°C for over 48 h, but not less than 48 h, was 
significantly associated with poorer prognosis in gastric 
cancer patients,10  indicating  that  fever duration might 
be also  important when considering  the correlation 
between  fever and prognosis.  In our  study, we  first 
determined the prognostic significance of postoperative 
fever duration and maximum postoperative  tempera-
ture. ROC analysis  for OS  indicated  that  the AUC of 
Table 1. Relationships between the duration of postoperative fever (≥ 37 degree) and clinicopathological vari-
ables in patients with gastric cancer
Variable Postoperative fever ≥ 37°C duration [mean ± SD (days)] P value
Age (years) 0.53
  < 70 (n = 216) 7.8 ± 11.0
  ≥ 70 (n = 226) 9.5 ± 16.3
Sex 0.95
 Male (n = 326) 9.3 ± 15.8
  Female (n = 116) 7.1 ± 6.1
Tumor size 0.11
  < 4 cm (n = 279) 8.0 ± 14.1
  ≥ 4 cm (n = 163) 9.8 ± 13.7
Histology 0.68
  Differentiated (n = 241) 8.2 ± 11.9
  Undifferentiated (n = 201) 9.3 ± 16.2
Depth of invasion 0.0072
 T1 (n = 282) 7.9 ± 14.0
 T2/T3/T4 (n = 160) 10.0 ± 13.8
Lymph node metastasis 0.081
  Absent (n = 340) 8.3 ± 14.5
 Present (n = 102) 9.8 ± 12.1
Lymphatic involvement 0.086
  Absent (n = 184) 7.1 ± 7.4
 Present (n = 258) 9.8 ± 17.1
Venous involvement 0.025
  Absent (n = 230) 6.9 ±7.1
 Present (n = 212) 10.6 ± 18.6
Stage of disease 0.073
 I (n = 308) 8.1 ± 13.8
 II / III (n = 134) 10.0 ± 14.5
Approach 0.027
 Open (n = 254) 9.2 ± 15.2
  Laparoscopy (n = 188) 8.1 ± 15.8
Lymph node dissection a 0.69
 D0 / 1 (n = 303) 9.0 ± 15.7
  D2 and more (n = 139) 8.1 ± 9.1
Gastrectomy 0.0015
 Total (n = 95) 11.4 ± 17.0
  Proximal and distal (n = 347) 7.9 ± 13.0
a Lymph node dissection: D0–D2, extent of lymph node dissection.
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Table 2. Multivariate analyses of factors prognostic of overall survival in patients with gastric cancer
Variable P value HR 95% CI
Age (years) a < 0.0001 1.063 1.043–1.084
Tumor size (cm) a 0.0012 1.119 1.046–1.197
Lymph node metastasis (N0–N3) b 0.021 1.28 1.037–1.579
Lymphatic involvement (Ly0–3) c 0.0047 1.424 1.114–1.821
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postoperative fever (≥ 37°C) duration was 0.6168, which 
was higher  than  that of postoperative  fever ≥ 37.5°C 
duration, postoperative  fever ≥ 38.0°C duration, or 
maximum postoperative  temperature,  indicating  that 
postoperative  fever ≥ 37°C duration was more useful 
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observed  in both  stage  I and stage  II  /  III,  indicating 
that postoperative  fever ≥ 37°C duration was a useful 
prognostic indicator regardless of stage of disease in 
GC patients. In fact, multivariate analysis indicated that 
postoperative fever ≥ 37°C duration was an independent 
prognostic  indicator. Of  importance  is  that NLR and 
PLR, which were though to reflect patient’s  inflamma-
tion status and were reported to be prognostic indicators 
in GC patients, were not independent prognostic indica-
tors  in  the current  study, emphasizing  the usefulness 
of postoperative fever ≥ 37°C duration as a prognostic 
indicator in GC patients.
Postoperative  fever ≥ 37°C duration was used 
for  survival analysis  in  the current  study. This does 
not mean  that 37°C, which  is close  to normal body 
temperature, has prognostic  impact.  In  this  regard, 
postoperative  fever ≥ 38°C durations was  significantly 
longer  in prolonged postoperative  fever group  than  in 
nonprolonged postoperative  fever group. Furthermore, 
maximum postoperative  temperature was  significantly 
higher  in prolonged postoperative  fever group  than  in 
nonprolonged postoperative fever group. Therefore, we 
think  that postoperative  fever ≥ 37°C duration  is one 











infectious complications  in our  study. Our  results also 
demonstrated  that postoperative  fever ≥ 37°C duration 
was significantly longer in those with postoperative 
infectious complications compared with  those without 
postoperative  infectious complications. Therefore,  it 
is likely that the poor prognosis seen in patients with 
prolonged postoperative  fever might be  secondary  to 
the presence of postoperative  infectious complications. 
However,  this was not supported  in our study because 







operative fever on prognosis in cancer patients are still 
poorly understood. Cytokines appear to play important 
roles and have been  implicated as pivotal mediators 
of  the pyrogenic or  antipyretic process,  including 
proinf lammatory  tumor necrosis  factor-alpha, and 
interleukin-6 and-1 as well  as  the anti-  inflammatory 
interleukin-1  receptor antagonist and  interleukin-10.16 
The  levels of cytokines with opposite  function deter-
mine  the occurrence and magnitude of  fever. Surgical 
and anesthetic  stress may elicit  an  imbalance between 
pro- and anti-inflammatory cytokines leading to fever.16 
Several  reports demonstrated a  stimulatory  role  for 
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tumor necrosis factor-alpha, and interleukin-1 and -6 in 





















tive  fever duration was also useful  in predicting  the 











surgeons  to  try  to minimize  the postoperative  inflam-












cut-off value  for postoperative  fever duration  remains 
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